HEADER OXIDOREDUCTASE 04-AUG-04 1U7T TITLE CRYSTAL STRUCTURE OF ABAD/HSD10 WITH A BOUND INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE TYPE II; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: TYPE II HADH, ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA- COMPND 5 PEPTIDE BINDING PROTEIN, SHORT-CHAIN TYPE DEHYDROGENASE/REDUCTASE COMPND 6 XH98G2, AMYLOID BETA-PEPTIDE-BINDING ALCOHOL DEHYDROGENASE, ABAD; COMPND 7 EC: 1.1.1.35; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HADH2, ERAB, XH98G2, SCHAD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMGH4 KEYWDS PROTEIN-INHIBITOR COMPLEX, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.R.KISSINGER,P.A.REJTO,L.A.PELLETIER,R.E.SHOWALTER,J.E.VILLAFRANCA REVDAT 6 03-APR-24 1U7T 1 REMARK REVDAT 5 14-FEB-24 1U7T 1 REMARK REVDAT 4 20-OCT-21 1U7T 1 REMARK SEQADV REVDAT 3 04-APR-18 1U7T 1 REMARK REVDAT 2 24-FEB-09 1U7T 1 VERSN REVDAT 1 05-OCT-04 1U7T 0 JRNL AUTH C.R.KISSINGER,P.A.REJTO,L.A.PELLETIER,J.A.THOMSON, JRNL AUTH 2 R.E.SHOWALTER,M.A.ABREO,C.S.AGREE,S.MARGOSIAK,J.J.MENG, JRNL AUTH 3 R.M.AUST,D.VANDERPOOL,B.LI,A.TEMPCZYK-RUSSELL, JRNL AUTH 4 J.E.VILLAFRANCA JRNL TITL CRYSTAL STRUCTURE OF HUMAN ABAD/HSD10 WITH A BOUND JRNL TITL 2 INHIBITOR: IMPLICATIONS FOR DESIGN OF ALZHEIMER'S DISEASE JRNL TITL 3 THERAPEUTICS JRNL REF J.MOL.BIOL. V. 342 943 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15342248 JRNL DOI 10.1016/J.JMB.2004.07.071 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.215 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.215 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3429 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 68595 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7224 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 254 REMARK 3 SOLVENT ATOMS : 282 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 1.500 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1U7T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1000023353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69169 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: WILD-TYPE HUMAN ABAD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MME-PEG 2000, SODIUM CITRATE, REMARK 280 ISOPROPANOL, PH 6.0, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.00000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS THE TETRAMER CONTAINED IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 21040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -116.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 CYS A 5 REMARK 465 ARG A 6 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 CYS B 5 REMARK 465 ARG B 6 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 ALA C 3 REMARK 465 ALA C 4 REMARK 465 CYS C 5 REMARK 465 ARG C 6 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 ALA D 3 REMARK 465 ALA D 4 REMARK 465 CYS D 5 REMARK 465 ARG D 6 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 7 OG REMARK 470 LYS A 9 CG CD CE NZ REMARK 470 LYS A 52 CG CD CE NZ REMARK 470 LYS A 69 CG CD CE NZ REMARK 470 LYS A 79 CG CD CE NZ REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 ARG A 116 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 138 CG CD OE1 NE2 REMARK 470 GLU A 140 CG CD OE1 OE2 REMARK 470 GLN A 143 CG CD OE1 NE2 REMARK 470 LYS A 212 CG CD CE NZ REMARK 470 SER B 7 OG REMARK 470 LYS B 9 CG CD CE NZ REMARK 470 LYS B 53 CG CD CE NZ REMARK 470 LYS B 69 CG CD CE NZ REMARK 470 LYS B 79 CG CD CE NZ REMARK 470 LYS B 104 CG CD CE NZ REMARK 470 GLN B 107 CG CD OE1 NE2 REMARK 470 ARG B 116 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 138 CG CD OE1 NE2 REMARK 470 GLU B 140 CG CD OE1 OE2 REMARK 470 GLN B 143 CG CD OE1 NE2 REMARK 470 LYS B 212 CG CD CE NZ REMARK 470 SER C 7 OG REMARK 470 LYS C 9 CG CD CE NZ REMARK 470 LYS C 53 CG CD CE NZ REMARK 470 LYS C 69 CG CD CE NZ REMARK 470 LYS C 79 CG CD CE NZ REMARK 470 LYS C 104 CG CD CE NZ REMARK 470 GLN C 107 CG CD OE1 NE2 REMARK 470 ARG C 116 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 138 CG CD OE1 NE2 REMARK 470 GLU C 140 CG CD OE1 OE2 REMARK 470 GLN C 143 CG CD OE1 NE2 REMARK 470 LYS C 212 CG CD CE NZ REMARK 470 SER D 7 OG REMARK 470 LYS D 9 CG CD CE NZ REMARK 470 LYS D 53 CG CD CE NZ REMARK 470 LYS D 69 CG CD CE NZ REMARK 470 LYS D 79 CG CD CE NZ REMARK 470 LYS D 104 CG CD CE NZ REMARK 470 GLN D 107 CG CD OE1 NE2 REMARK 470 ARG D 116 CG CD NE CZ NH1 NH2 REMARK 470 GLN D 138 CG CD OE1 NE2 REMARK 470 GLU D 140 CG CD OE1 OE2 REMARK 470 GLN D 143 CG CD OE1 NE2 REMARK 470 LYS D 212 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 63 144.97 -173.44 REMARK 500 LEU A 122 -61.49 -101.87 REMARK 500 ALA A 154 -124.79 -98.48 REMARK 500 SER A 155 157.25 177.54 REMARK 500 ASP A 254 10.52 -154.43 REMARK 500 LEU B 122 -61.94 -102.31 REMARK 500 ALA B 154 -127.01 -95.60 REMARK 500 SER B 155 153.79 178.88 REMARK 500 ASP B 254 12.79 -157.06 REMARK 500 ALA C 154 -127.75 -97.23 REMARK 500 SER C 155 152.70 179.87 REMARK 500 ASP C 254 15.43 -157.14 REMARK 500 ALA C 256 14.96 80.39 REMARK 500 ALA D 63 148.82 -173.29 REMARK 500 ALA D 154 -127.39 -97.57 REMARK 500 SER D 208 2.00 -67.64 REMARK 500 ASP D 254 16.25 -155.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TDT A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TDT C 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TDT D 504 DBREF 1U7T A 1 261 UNP Q99714 HCD2_HUMAN 1 261 DBREF 1U7T B 1 261 UNP Q99714 HCD2_HUMAN 1 261 DBREF 1U7T C 1 261 UNP Q99714 HCD2_HUMAN 1 261 DBREF 1U7T D 1 261 UNP Q99714 HCD2_HUMAN 1 261 SEQADV 1U7T ARG A 214 UNP Q99714 CYS 214 ENGINEERED MUTATION SEQADV 1U7T ARG B 214 UNP Q99714 CYS 214 ENGINEERED MUTATION SEQADV 1U7T ARG C 214 UNP Q99714 CYS 214 ENGINEERED MUTATION SEQADV 1U7T ARG D 214 UNP Q99714 CYS 214 ENGINEERED MUTATION SEQRES 1 A 261 MET ALA ALA ALA CYS ARG SER VAL LYS GLY LEU VAL ALA SEQRES 2 A 261 VAL ILE THR GLY GLY ALA SER GLY LEU GLY LEU ALA THR SEQRES 3 A 261 ALA GLU ARG LEU VAL GLY GLN GLY ALA SER ALA VAL LEU SEQRES 4 A 261 LEU ASP LEU PRO ASN SER GLY GLY GLU ALA GLN ALA LYS SEQRES 5 A 261 LYS LEU GLY ASN ASN CYS VAL PHE ALA PRO ALA ASP VAL SEQRES 6 A 261 THR SER GLU LYS ASP VAL GLN THR ALA LEU ALA LEU ALA SEQRES 7 A 261 LYS GLY LYS PHE GLY ARG VAL ASP VAL ALA VAL ASN CYS SEQRES 8 A 261 ALA GLY ILE ALA VAL ALA SER LYS THR TYR ASN LEU LYS SEQRES 9 A 261 LYS GLY GLN THR HIS THR LEU GLU ASP PHE GLN ARG VAL SEQRES 10 A 261 LEU ASP VAL ASN LEU MET GLY THR PHE ASN VAL ILE ARG SEQRES 11 A 261 LEU VAL ALA GLY GLU MET GLY GLN ASN GLU PRO ASP GLN SEQRES 12 A 261 GLY GLY GLN ARG GLY VAL ILE ILE ASN THR ALA SER VAL SEQRES 13 A 261 ALA ALA PHE GLU GLY GLN VAL GLY GLN ALA ALA TYR SER SEQRES 14 A 261 ALA SER LYS GLY GLY ILE VAL GLY MET THR LEU PRO ILE SEQRES 15 A 261 ALA ARG ASP LEU ALA PRO ILE GLY ILE ARG VAL MET THR SEQRES 16 A 261 ILE ALA PRO GLY LEU PHE GLY THR PRO LEU LEU THR SER SEQRES 17 A 261 LEU PRO GLU LYS VAL ARG ASN PHE LEU ALA SER GLN VAL SEQRES 18 A 261 PRO PHE PRO SER ARG LEU GLY ASP PRO ALA GLU TYR ALA SEQRES 19 A 261 HIS LEU VAL GLN ALA ILE ILE GLU ASN PRO PHE LEU ASN SEQRES 20 A 261 GLY GLU VAL ILE ARG LEU ASP GLY ALA ILE ARG MET GLN SEQRES 21 A 261 PRO SEQRES 1 B 261 MET ALA ALA ALA CYS ARG SER VAL LYS GLY LEU VAL ALA SEQRES 2 B 261 VAL ILE THR GLY GLY ALA SER GLY LEU GLY LEU ALA THR SEQRES 3 B 261 ALA GLU ARG LEU VAL GLY GLN GLY ALA SER ALA VAL LEU SEQRES 4 B 261 LEU ASP LEU PRO ASN SER GLY GLY GLU ALA GLN ALA LYS SEQRES 5 B 261 LYS LEU GLY ASN ASN CYS VAL PHE ALA PRO ALA ASP VAL SEQRES 6 B 261 THR SER GLU LYS ASP VAL GLN THR ALA LEU ALA LEU ALA SEQRES 7 B 261 LYS GLY LYS PHE GLY ARG VAL ASP VAL ALA VAL ASN CYS SEQRES 8 B 261 ALA GLY ILE ALA VAL ALA SER LYS THR TYR ASN LEU LYS SEQRES 9 B 261 LYS GLY GLN THR HIS THR LEU GLU ASP PHE GLN ARG VAL SEQRES 10 B 261 LEU ASP VAL ASN LEU MET GLY THR PHE ASN VAL ILE ARG SEQRES 11 B 261 LEU VAL ALA GLY GLU MET GLY GLN ASN GLU PRO ASP GLN SEQRES 12 B 261 GLY GLY GLN ARG GLY VAL ILE ILE ASN THR ALA SER VAL SEQRES 13 B 261 ALA ALA PHE GLU GLY GLN VAL GLY GLN ALA ALA TYR SER SEQRES 14 B 261 ALA SER LYS GLY GLY ILE VAL GLY MET THR LEU PRO ILE SEQRES 15 B 261 ALA ARG ASP LEU ALA PRO ILE GLY ILE ARG VAL MET THR SEQRES 16 B 261 ILE ALA PRO GLY LEU PHE GLY THR PRO LEU LEU THR SER SEQRES 17 B 261 LEU PRO GLU LYS VAL ARG ASN PHE LEU ALA SER GLN VAL SEQRES 18 B 261 PRO PHE PRO SER ARG LEU GLY ASP PRO ALA GLU TYR ALA SEQRES 19 B 261 HIS LEU VAL GLN ALA ILE ILE GLU ASN PRO PHE LEU ASN SEQRES 20 B 261 GLY GLU VAL ILE ARG LEU ASP GLY ALA ILE ARG MET GLN SEQRES 21 B 261 PRO SEQRES 1 C 261 MET ALA ALA ALA CYS ARG SER VAL LYS GLY LEU VAL ALA SEQRES 2 C 261 VAL ILE THR GLY GLY ALA SER GLY LEU GLY LEU ALA THR SEQRES 3 C 261 ALA GLU ARG LEU VAL GLY GLN GLY ALA SER ALA VAL LEU SEQRES 4 C 261 LEU ASP LEU PRO ASN SER GLY GLY GLU ALA GLN ALA LYS SEQRES 5 C 261 LYS LEU GLY ASN ASN CYS VAL PHE ALA PRO ALA ASP VAL SEQRES 6 C 261 THR SER GLU LYS ASP VAL GLN THR ALA LEU ALA LEU ALA SEQRES 7 C 261 LYS GLY LYS PHE GLY ARG VAL ASP VAL ALA VAL ASN CYS SEQRES 8 C 261 ALA GLY ILE ALA VAL ALA SER LYS THR TYR ASN LEU LYS SEQRES 9 C 261 LYS GLY GLN THR HIS THR LEU GLU ASP PHE GLN ARG VAL SEQRES 10 C 261 LEU ASP VAL ASN LEU MET GLY THR PHE ASN VAL ILE ARG SEQRES 11 C 261 LEU VAL ALA GLY GLU MET GLY GLN ASN GLU PRO ASP GLN SEQRES 12 C 261 GLY GLY GLN ARG GLY VAL ILE ILE ASN THR ALA SER VAL SEQRES 13 C 261 ALA ALA PHE GLU GLY GLN VAL GLY GLN ALA ALA TYR SER SEQRES 14 C 261 ALA SER LYS GLY GLY ILE VAL GLY MET THR LEU PRO ILE SEQRES 15 C 261 ALA ARG ASP LEU ALA PRO ILE GLY ILE ARG VAL MET THR SEQRES 16 C 261 ILE ALA PRO GLY LEU PHE GLY THR PRO LEU LEU THR SER SEQRES 17 C 261 LEU PRO GLU LYS VAL ARG ASN PHE LEU ALA SER GLN VAL SEQRES 18 C 261 PRO PHE PRO SER ARG LEU GLY ASP PRO ALA GLU TYR ALA SEQRES 19 C 261 HIS LEU VAL GLN ALA ILE ILE GLU ASN PRO PHE LEU ASN SEQRES 20 C 261 GLY GLU VAL ILE ARG LEU ASP GLY ALA ILE ARG MET GLN SEQRES 21 C 261 PRO SEQRES 1 D 261 MET ALA ALA ALA CYS ARG SER VAL LYS GLY LEU VAL ALA SEQRES 2 D 261 VAL ILE THR GLY GLY ALA SER GLY LEU GLY LEU ALA THR SEQRES 3 D 261 ALA GLU ARG LEU VAL GLY GLN GLY ALA SER ALA VAL LEU SEQRES 4 D 261 LEU ASP LEU PRO ASN SER GLY GLY GLU ALA GLN ALA LYS SEQRES 5 D 261 LYS LEU GLY ASN ASN CYS VAL PHE ALA PRO ALA ASP VAL SEQRES 6 D 261 THR SER GLU LYS ASP VAL GLN THR ALA LEU ALA LEU ALA SEQRES 7 D 261 LYS GLY LYS PHE GLY ARG VAL ASP VAL ALA VAL ASN CYS SEQRES 8 D 261 ALA GLY ILE ALA VAL ALA SER LYS THR TYR ASN LEU LYS SEQRES 9 D 261 LYS GLY GLN THR HIS THR LEU GLU ASP PHE GLN ARG VAL SEQRES 10 D 261 LEU ASP VAL ASN LEU MET GLY THR PHE ASN VAL ILE ARG SEQRES 11 D 261 LEU VAL ALA GLY GLU MET GLY GLN ASN GLU PRO ASP GLN SEQRES 12 D 261 GLY GLY GLN ARG GLY VAL ILE ILE ASN THR ALA SER VAL SEQRES 13 D 261 ALA ALA PHE GLU GLY GLN VAL GLY GLN ALA ALA TYR SER SEQRES 14 D 261 ALA SER LYS GLY GLY ILE VAL GLY MET THR LEU PRO ILE SEQRES 15 D 261 ALA ARG ASP LEU ALA PRO ILE GLY ILE ARG VAL MET THR SEQRES 16 D 261 ILE ALA PRO GLY LEU PHE GLY THR PRO LEU LEU THR SER SEQRES 17 D 261 LEU PRO GLU LYS VAL ARG ASN PHE LEU ALA SER GLN VAL SEQRES 18 D 261 PRO PHE PRO SER ARG LEU GLY ASP PRO ALA GLU TYR ALA SEQRES 19 D 261 HIS LEU VAL GLN ALA ILE ILE GLU ASN PRO PHE LEU ASN SEQRES 20 D 261 GLY GLU VAL ILE ARG LEU ASP GLY ALA ILE ARG MET GLN SEQRES 21 D 261 PRO HET TDT A 501 70 HET NAD B 502 44 HET TDT C 503 70 HET TDT D 504 70 HETNAM TDT 1-AZEPAN-1-YL-2-PHENYL-2-(4-THIOXO-1,4-DIHYDRO- HETNAM 2 TDT PYRAZOLO[3,4-D]PYRIMIDIN-5-YL)ETHANONE ADDUCT HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 5 TDT 3(C40 H44 N12 O15 P2 S 4-) FORMUL 6 NAD C21 H27 N7 O14 P2 FORMUL 9 HOH *282(H2 O) HELIX 1 1 SER A 20 GLN A 33 1 14 HELIX 2 2 GLY A 46 GLY A 55 1 10 HELIX 3 3 SER A 67 GLY A 83 1 17 HELIX 4 4 THR A 110 LEU A 122 1 13 HELIX 5 5 LEU A 122 GLY A 137 1 16 HELIX 6 6 VAL A 156 GLY A 161 1 6 HELIX 7 7 GLN A 165 ALA A 187 1 23 HELIX 8 8 THR A 203 LEU A 209 5 7 HELIX 9 9 PRO A 210 GLN A 220 1 11 HELIX 10 10 ASP A 229 ASN A 243 1 15 HELIX 11 11 SER B 20 GLN B 33 1 14 HELIX 12 12 GLY B 46 GLY B 55 1 10 HELIX 13 13 SER B 67 GLY B 83 1 17 HELIX 14 14 THR B 110 LEU B 122 1 13 HELIX 15 15 LEU B 122 GLY B 137 1 16 HELIX 16 16 VAL B 156 GLY B 161 1 6 HELIX 17 17 GLN B 165 ALA B 187 1 23 HELIX 18 18 THR B 203 SER B 208 1 6 HELIX 19 19 PRO B 210 SER B 219 1 10 HELIX 20 20 ASP B 229 ASN B 243 1 15 HELIX 21 21 SER C 20 GLN C 33 1 14 HELIX 22 22 GLY C 46 GLY C 55 1 10 HELIX 23 23 SER C 67 GLY C 83 1 17 HELIX 24 24 THR C 110 LEU C 122 1 13 HELIX 25 25 LEU C 122 GLN C 138 1 17 HELIX 26 26 VAL C 156 GLY C 161 1 6 HELIX 27 27 GLN C 165 ALA C 187 1 23 HELIX 28 28 THR C 203 LEU C 209 5 7 HELIX 29 29 PRO C 210 GLN C 220 1 11 HELIX 30 30 ASP C 229 ASN C 243 1 15 HELIX 31 31 SER D 20 GLN D 33 1 14 HELIX 32 32 GLY D 46 GLY D 55 1 10 HELIX 33 33 SER D 67 GLY D 83 1 17 HELIX 34 34 THR D 110 LEU D 122 1 13 HELIX 35 35 LEU D 122 GLN D 138 1 17 HELIX 36 36 VAL D 156 GLY D 161 1 6 HELIX 37 37 GLN D 165 ALA D 187 1 23 HELIX 38 38 PRO D 188 GLY D 190 5 3 HELIX 39 39 THR D 203 THR D 207 5 5 HELIX 40 40 PRO D 210 GLN D 220 1 11 HELIX 41 41 ASP D 229 ASN D 243 1 15 SHEET 1 A 7 CYS A 58 PRO A 62 0 SHEET 2 A 7 SER A 36 ASP A 41 1 N LEU A 39 O VAL A 59 SHEET 3 A 7 VAL A 12 THR A 16 1 N ILE A 15 O VAL A 38 SHEET 4 A 7 VAL A 87 ASN A 90 1 O VAL A 87 N VAL A 14 SHEET 5 A 7 GLY A 148 THR A 153 1 O ILE A 151 N ALA A 88 SHEET 6 A 7 ILE A 191 PRO A 198 1 O ILE A 196 N ASN A 152 SHEET 7 A 7 VAL A 250 LEU A 253 1 O ILE A 251 N ALA A 197 SHEET 1 B 2 TYR A 101 ASN A 102 0 SHEET 2 B 2 GLN A 107 THR A 108 -1 O GLN A 107 N ASN A 102 SHEET 1 C 7 CYS B 58 PRO B 62 0 SHEET 2 C 7 SER B 36 ASP B 41 1 N LEU B 39 O VAL B 59 SHEET 3 C 7 VAL B 12 THR B 16 1 N ILE B 15 O VAL B 38 SHEET 4 C 7 VAL B 87 ASN B 90 1 O VAL B 87 N VAL B 14 SHEET 5 C 7 GLY B 148 THR B 153 1 O ILE B 151 N ALA B 88 SHEET 6 C 7 ILE B 191 PRO B 198 1 O ARG B 192 N ILE B 150 SHEET 7 C 7 VAL B 250 LEU B 253 1 O ILE B 251 N ALA B 197 SHEET 1 D 2 TYR B 101 ASN B 102 0 SHEET 2 D 2 GLN B 107 THR B 108 -1 O GLN B 107 N ASN B 102 SHEET 1 E 7 CYS C 58 PRO C 62 0 SHEET 2 E 7 SER C 36 ASP C 41 1 N LEU C 39 O VAL C 59 SHEET 3 E 7 VAL C 12 THR C 16 1 N ILE C 15 O VAL C 38 SHEET 4 E 7 VAL C 87 ASN C 90 1 O VAL C 87 N VAL C 14 SHEET 5 E 7 GLY C 148 THR C 153 1 O ILE C 151 N ASN C 90 SHEET 6 E 7 ILE C 191 PRO C 198 1 O MET C 194 N ILE C 150 SHEET 7 E 7 VAL C 250 LEU C 253 1 O ILE C 251 N ALA C 197 SHEET 1 F 2 TYR C 101 ASN C 102 0 SHEET 2 F 2 GLN C 107 THR C 108 -1 O GLN C 107 N ASN C 102 SHEET 1 G 7 CYS D 58 PRO D 62 0 SHEET 2 G 7 SER D 36 ASP D 41 1 N LEU D 39 O ALA D 61 SHEET 3 G 7 VAL D 12 THR D 16 1 N ALA D 13 O SER D 36 SHEET 4 G 7 VAL D 87 ASN D 90 1 O VAL D 87 N VAL D 14 SHEET 5 G 7 VAL D 149 THR D 153 1 O ILE D 151 N ALA D 88 SHEET 6 G 7 ARG D 192 PRO D 198 1 O MET D 194 N ILE D 150 SHEET 7 G 7 VAL D 250 LEU D 253 1 O ILE D 251 N ALA D 197 SHEET 1 H 2 TYR D 101 ASN D 102 0 SHEET 2 H 2 GLN D 107 THR D 108 -1 O GLN D 107 N ASN D 102 CISPEP 1 PHE A 223 PRO A 224 0 -1.13 CISPEP 2 PHE B 223 PRO B 224 0 -3.17 CISPEP 3 PHE C 223 PRO C 224 0 -0.53 CISPEP 4 PHE D 223 PRO D 224 0 -4.32 SITE 1 AC1 36 GLY A 17 SER A 20 GLY A 21 LEU A 22 SITE 2 AC1 36 ASP A 41 LEU A 42 ALA A 63 ASP A 64 SITE 3 AC1 36 VAL A 65 CYS A 91 ALA A 92 GLY A 93 SITE 4 AC1 36 ALA A 95 VAL A 96 ALA A 97 VAL A 120 SITE 5 AC1 36 THR A 153 ALA A 154 SER A 155 GLN A 162 SITE 6 AC1 36 VAL A 163 GLN A 165 TYR A 168 LYS A 172 SITE 7 AC1 36 PRO A 198 GLY A 199 LEU A 200 PHE A 201 SITE 8 AC1 36 THR A 203 PRO A 204 LEU A 205 LEU A 206 SITE 9 AC1 36 HOH A 504 HOH A 530 HOH A 565 HOH A 567 SITE 1 AC2 27 GLY B 17 SER B 20 GLY B 21 LEU B 22 SITE 2 AC2 27 ASP B 41 LEU B 42 ALA B 63 ASP B 64 SITE 3 AC2 27 VAL B 65 CYS B 91 ALA B 92 GLY B 93 SITE 4 AC2 27 THR B 153 ALA B 154 SER B 155 TYR B 168 SITE 5 AC2 27 LYS B 172 PRO B 198 GLY B 199 PHE B 201 SITE 6 AC2 27 THR B 203 PRO B 204 LEU B 206 HOH B 506 SITE 7 AC2 27 HOH B 524 HOH B 543 HOH B 551 SITE 1 AC3 37 GLY C 17 SER C 20 GLY C 21 LEU C 22 SITE 2 AC3 37 ASP C 41 ALA C 63 ASP C 64 VAL C 65 SITE 3 AC3 37 CYS C 91 ALA C 92 GLY C 93 ALA C 95 SITE 4 AC3 37 ALA C 97 VAL C 120 THR C 153 ALA C 154 SITE 5 AC3 37 SER C 155 GLN C 162 VAL C 163 GLN C 165 SITE 6 AC3 37 TYR C 168 LYS C 172 PRO C 198 GLY C 199 SITE 7 AC3 37 LEU C 200 PHE C 201 THR C 203 PRO C 204 SITE 8 AC3 37 LEU C 205 LEU C 206 LEU C 209 HOH C 507 SITE 9 AC3 37 HOH C 509 HOH C 538 HOH C 545 HOH C 552 SITE 10 AC3 37 HOH C 556 SITE 1 AC4 37 GLY D 17 SER D 20 GLY D 21 LEU D 22 SITE 2 AC4 37 ASP D 41 LEU D 42 ALA D 63 ASP D 64 SITE 3 AC4 37 VAL D 65 CYS D 91 ALA D 92 GLY D 93 SITE 4 AC4 37 ALA D 95 VAL D 120 THR D 153 ALA D 154 SITE 5 AC4 37 SER D 155 GLN D 162 VAL D 163 GLN D 165 SITE 6 AC4 37 TYR D 168 LYS D 172 PRO D 198 GLY D 199 SITE 7 AC4 37 LEU D 200 PHE D 201 THR D 203 PRO D 204 SITE 8 AC4 37 LEU D 205 SER D 208 LEU D 209 HOH D 526 SITE 9 AC4 37 HOH D 544 HOH D 561 HOH D 570 HOH D 571 SITE 10 AC4 37 HOH D 575 CRYST1 122.000 80.800 110.000 90.00 105.60 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008197 0.000000 0.002289 0.00000 SCALE2 0.000000 0.012376 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009439 0.00000